CONMED CORP (CNMD) Stock Analyst Ratings
USA • New York Stock Exchange • NYSE:CNMD • US2074101013
42.8 USD
+1.13 (+2.71%)
At close: Feb 10, 2026
42.8 USD
0 (0%)
Pre-Market: 2/11/2026, 4:12:57 AM
ChartMill assigns a Buy % Consensus number of 73% to CNMD. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 49.57. This target is 15.82% above the current price.
- CNMD was analyzed by 12 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about CNMD.
- In the previous month the buy percentage consensus was at a similar level.
- CNMD was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-29 | Needham | Reiterate | Hold -> Hold |
| 2026-01-29 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-08 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-11-06 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-06 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-11-06 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-07-31 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-06-12 | Needham | Downgrade | Buy -> Hold |
| 2025-05-01 | Needham | Maintains | Buy -> Buy |
| 2025-05-01 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-01 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-04-28 | Stifel | Downgrade | Buy -> Hold |
| 2025-02-06 | Needham | Maintains | Buy -> Buy |
| 2025-02-06 | Stifel | Maintains | Buy -> Buy |
| 2025-02-06 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-06 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2024-10-31 | Needham | Reiterate | Buy -> Buy |
| 2024-10-04 | Needham | Reiterate | Buy -> Buy |
| 2024-08-01 | Needham | Maintains | Buy -> Buy |
| 2024-08-01 | Stifel | Maintains | Buy -> Buy |
| 2024-08-01 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-08-01 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-07-25 | Needham | Maintains | Buy -> Buy |
| 2024-05-06 | Needham | Reiterate | Buy -> Buy |
| 2024-04-25 | Needham | Maintains | Buy -> Buy |
| 2024-04-25 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-04-25 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-04-25 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-02-01 | Needham | Maintains | Buy -> Buy |
| 2024-02-01 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
CONMED CORP / CNMD FAQ
What is the price target for CNMD stock?
12 analysts have analysed CNMD and the average price target is 49.57 USD. This implies a price increase of 15.82% is expected in the next year compared to the current price of 42.8.
Can you provide the consensus rating for CONMED CORP stock?
The consensus rating for CONMED CORP (CNMD) is 73.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.